Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLXNA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WDR74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CASC22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSRC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UFC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICAM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PITPNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPRE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDCBP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGES3L-AARSD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTBP1-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3H7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSMAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on